Psilocybin‐assisted therapy reduces heavy drinking in patients with AUD
The Brown University Psychopharmacology Update – November 03, 2022
Source: OpenAlex
Summary
Two sessions of psilocybin-assisted psychotherapy significantly reduced heavy drinking and alcohol-related problems for individuals with alcohol use disorder, outperforming placebo. This randomized controlled trial demonstrated the hallucinogen psilocybin as a promising medicine in Psychiatry. Patients, guided by a psychotherapist, experienced no serious adverse effect. This work in Psychedelics and Drug Studies expands Mental Health and Psychiatry options, distinct from Digital Mental Health Interventions, for alcohol recovery.
Abstract
Two sessions of psilocybin‐assisted psychotherapy resulted in reduced heavy‐drinking days and other alcohol‐related problems relative to placebo plus psychotherapy in a randomized trial involving patients with alcohol use disorder (AUD). There were no serious adverse events associated with psilocybin administration, and no signs of psychotic disturbances. Study results were published online Aug. 24, 2022, in JAMA Psychiatry .